3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
15
Terminated
6
Withdrawn
2
Unknown
2
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
1
Fatigue
1
Cognitive Dysfunction
1
Interventions
Magnetic Resonance Spectroscopy
332
Specimen Handling
331
Radiotherapy
315
Cyclophosphamide
298
pembrolizumab
286
Cisplatin
270
Carboplatin
247
Drug Therapy
238
Blood Specimen Collection
234
Biopsy
203
Bevacizumab
185
Gemcitabine
181
venetoclax
177
Radiosurgery
170
Oxaliplatin
164
Capecitabine
163
fludarabine
161
Paclitaxel
158
Nivolumab
157
Standard of Care
135
Surveys and Questionnaires
132
Surgical Procedures, Operative
130
Dexamethasone
126
Fluorouracil
123
Rituximab
113
Docetaxel
112
tislelizumab
111
Cytarabine
106
toripalimab
101
Radiation
101
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
OTHER
×
Modafinil
×
Clear all
NCT05333250
2026-01-13
MODIFY
Ottawa Hospital Research Institute
Phase 1/2
Recruiting
40 enrolled